Aveanna Healthcare (US.AVAH)
Capital Allocation Audit · Period: 2018 – 2026
Key Metrics
US.AVAH · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | -4.8% | ↓ |
| ROE | 17.3% | → |
| Cash Conversion | 10.4% | ↑ |
| D/E Ratio | 6.24 | → |
| Gross Margin | 31.7% | → |
US.AVAH (Aveanna Healthcare) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY --------------------------- FCF Conversion -4.8% ↓ ROE 17.3% → Cash Conversion 10.4% ↑ D/E Ratio 6.24 → Gross Margin 31.7% →
Key Metrics
US.AVAH (Aveanna Healthcare) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY---------------------------FCF Conversion -4.8% ↓ROE 17.3% →Cash Conversion 10.4% ↑D/E Ratio 6.24 →Gross Margin 31.7% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies